Lv3
250 积分 2025-04-03 加入
Mechanisms of resistance to antibody–drug conjugates in cancers
16小时前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
20天前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
23天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
24天前
已完结
The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future'
24天前
已完结
'The Next Wave After Immunotherapy in Cancer Drug Development—Back to the Future'
25天前
已关闭
Autoamputation in Mismatch Repair–Deficient Colon Cancer
1个月前
已完结
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials
1个月前
已完结
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
1个月前
已完结
表皮生长因子受体酪氨酸激酶抑制剂药物相互作用概述
1个月前
已完结
皖公网安备34019202002308
